|
AHR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.24070000001786E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.73839999751647E-08 |
| Normal-vs-Stage2 |
7.624300E-03 |
| Normal-vs-Stage3 |
1.363220E-03 |
| Normal-vs-Stage4 |
8.225800E-04 |
| Stage1-vs-Stage2 |
1.371810E-01 |
| Stage1-vs-Stage3 |
1.354190E-01 |
| Stage1-vs-Stage4 |
1.142640E-01 |
| Stage2-vs-Stage3 |
8.776400E-01 |
| Stage2-vs-Stage4 |
8.770400E-01 |
| Stage3-vs-Stage4 |
9.827200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11769999999733E-06 |
| Normal-vs-AfricanAmerican |
2.641500E-02 |
| Normal-vs-Asian |
1.046620E-01 |
| Caucasian-vs-AfricanAmerican |
1.050800E-01 |
| Caucasian-vs-Asian |
2.263800E-01 |
| AfricanAmerican-vs-Asian |
1.713630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.70600000038679E-07 |
| Normal-vs-Female |
8.45350000000522E-05 |
| Male-vs-Female |
4.572200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.011530E-02 |
| Normal-vs-Age(41-60Yrs) |
6.80650000028926E-07 |
| Normal-vs-Age(61-80Yrs) |
2.14669999999417E-05 |
| Normal-vs-Age(81-100Yrs) |
1.242290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.683800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.915600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.180400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.965200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.890200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.857000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.713600E-02 |
| Normal-vs-Grade 2 |
3.8098999999292E-07 |
| Normal-vs-Grade 3 |
4.18140000000289E-05 |
| Normal-vs-Grade 4 |
1.002220E-02 |
| Grade 1-vs-Grade 2 |
4.061800E-01 |
| Grade 1-vs-Grade 3 |
2.428800E-01 |
| Grade 1-vs-Grade 4 |
2.315800E-01 |
| Grade 2-vs-Grade 3 |
4.250100E-02 |
| Grade 2-vs-Grade 4 |
1.745000E-01 |
| Grade 3-vs-Grade 4 |
8.356600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.38009999884181E-08 |
| Normal-vs-ccB subtype |
1.594430E-04 |
| ccA subtype-vs-ccB subtype |
6.103900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.80949999999802E-05 |
| Normal-vs-N1 |
4.284200E-02 |
| N0-vs-N1 |
9.631200E-01 |
|
|
